STXS stock

Stereotaxis Inc (STXS) stock news · rev $32.4M

Stereotaxis Inc (STXS) is a medical instruments & supplies company listed on AMEX.

This STXS news page leads with what Stereotaxis Inc filed — not a scraped headline mill.

No cached 8-K sentence for STXS yet. We will not pad this page with generic market recap.

Latest reported STXS revenue for 2025-12-31 was $32.4M. Net income was -$21.6M. Revenue was up 20.3% from 2024-12-31 to 2025-12-31. STXS currently screens at market cap $174.0M.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the STXS stock page; for the tape open the quote page.

STXS stock news FAQ

What are STXS's latest revenue and net income?

Latest cached Stereotaxis Inc (STXS) revenue for Dec 31, 2025 was $32.4M. Net income was -$21.6M. Statements: https://lician.com/financials/stxs

How did STXS revenue change from the prior cached period?

Cached Stereotaxis Inc (STXS) revenue was up 20.3% from $26.9M (Dec 31, 2024) to $32.4M (Dec 31, 2025). Statements: https://lician.com/financials/stxs

What is STXS's market cap?

Stereotaxis Inc (STXS) market cap is $174.0M on the latest cached fundamentals snapshot.

What kind of company is STXS?

Stereotaxis Inc (STXS) is a medical instruments & supplies company listed on AMEX.

Where is STXS stock news listed?

Cached stock news for Stereotaxis Inc (STXS) is listed at https://lician.com/news/stxs. Filings: https://lician.com/sec/stxs

Not investment advice.

Full STXS analysis